CovalX AG was founded in 2006. The company's vision is to become a leading provider of technology and services in the field of protein interaction analysis based on mass spectrometry. With support offices in Switzerland, France, and the USA, CovalX is a global company offering leading product and services for major pharmaceutical companies as well as academic laboratories. CovalX High-Mass systems and services are sold worldwide through direct offices (Europe, USA) or distributors (China, Japan, Korea). CovalX is a fast-growing company, developing innovative analysis solutions for the characterization of therapeutic proteins and protein interactions for the life science industry.